ClinicalTrials.gg
RecruitingNCT03969628Updated Apr 25, 2023

CARDEC-PEL: Comparison of Two Methods of Caries Risk Assessment in Children

An interventional study of ICCMS in Caries,Dental, sponsored by Federal University of Pelotas. Recruiting at 1 site in Brazil. Open to participants aged 7 Years to 11 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-04-25.

Sponsored by Federal University of Pelotas · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 5 months ago, but the record still lists the study as recruiting.
  • Started Jun 2019; still recruiting 7 years 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
250
Allocation
Randomized
Ages
7 Years to 11 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 82 studies in Dental Caries with a site in Brazil — 5 open to participants now, 6 under way, none of them phase 3. Dental Caries · Brazil.

Planned enrollment
17th of 79
250 · median 119
Started
2019
with 5 others
No phase
57 of 82
4 open now
Registered
64th of 82
by date
Lead sponsor
3 of 82
Federal University of Pelotas

Among the 82 studies in Dental Caries with a site in Brazil, this one is the 17th largest by planned enrollment of the 79 interventional ones, is one of 6 that started in 2019, is one of 57 with no phase, and was the 64th registered.

By phase

82 studies; the count open now beside each. This study's row is marked.

No phasethis study57 · 4 open
Phase 19 · 0 open
Phase 36 · 0 open
Phase 44 · 1 open
Observational3 · 0 open
Phase 1/21 · 0 open
Phase 21 · 0 open
Phase 2/31 · 0 open

By the year they started

First in 2001; this study’s year is marked. 6 started in 2019.

Size and results

Median enrollment 119 across the 79 interventional studies, 200 across the 3 observational. Of the 50 that completed or were terminated, 2 (4%) have results posted.

Was this useful?
Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 82 studies in Dental Caries with a site in Brazil, or all of them as a file.
02

Study summary

The aim of the study was to compare dental caries treatment and follow-up based on an elaborate and individualized assessment of caries risk in children, to a simpler risk assessment strategy by means of a double-blind randomized clinical trial of two years monitoring. Participants will be children from 7 to 11 years old, who pass through the screening of the Children's Clinic of the Faculty of Dentistry of the Federal University of Pelotas and fulfill the inclusion criteria. A randomized, stratified sample of approximately 250 children will be included in the study, one group will be composed of children undergoing dental caries-related treatment and maintenance, guided by an individualized and multivariate risk assessment, and another group of children treated based on dental caries experience alone in the deciduous and / or permanent dentition. Recruitment will begin at the beginning of 2019, and participants will be followed up for 24 months. Parents will respond to an anamnesis, 24-hour dietary recall, food frequency questionnaire, and oral and general health-related quality of life questionnaire, children will undergo a clinical examination to assess caries, according to the International Caries Detection and Assessment System (ICDAS) in its simplified form and evaluation of caries activity. Dental treatments and return intervals will be designated according to the individual risk of the patient detected in the initial approach according to the group. The study evaluations consist of baseline, 12 months and 24 months, data will be transferred to spreadsheets after the different phases of the study. Primary outcomes (number of dental surfaces requiring operative intervention) and secondary outcomes will be analyzed by Student's t test, quality of life and quality of life related to oral health, will be assessed at the beginning of the study and at the end of treatment, and compared between the groups.

03

Conditions studied

  • Caries,Dental

Browse trials for

04

Who can participate

Ages eligible
7 Years to 11 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals aged 7 years months to 11 years;
  • Children seeking dental treatment at the Pediatric dentistry university clinic in Pelotas (UFPel)

Exclusion criteria

Exclusion Criteria:

  • Medical and/or behavioral conditions that requires special considerations regarding management/treatment of the child
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
250 participants (estimated)

Study arms

  • Experimental
    Multivariate risk assessment group (ICCMS®)

    Multivariate risk assessment group (ICCMS®): multivariate caries risk assessment based on International Caries Classification and Management System (ICCMS™) guide

    Diagnostic Test: ICCMS

  • Experimental
    Simplified risk assessment group (dental caries experience)

    Simplified risk assessment group (dental caries experience): simplified caries risk assessment based on dental caries experience (WHO criteria)

    Diagnostic Test: ICCMS

Interventions

  • Diagnostic testICCMS

    Risk caries assessment will consider ICCMS criteria

06

What researchers measure

Primary outcomes

  1. New caries lesions

    Incremental number of dental surfaces with operative treatment needs. This outcome will be assessed by the new caries lesions and / or progression of lesions previously diagnosed / treated and number of treated surfaces which will need restoration replacement, endodontic treatment or extraction after the treatment plan.

    Time frame: from baseline (first measurement) to 24months

Secondary outcomes

  1. Quality of life score

    Impact on oral health related quality of life measured by a validated questionnaire (CPQ)

    Time frame: from baseline (first measurement) to 24months

07

Study locations

1 of 1 sites recruiting
  • Graduate Program in Dentistry
    Pelotas, RS 96015080, Brazil
    Recruiting
    • Maximiliano S Cenci, PhD · Contactcencims@gmail.com · 555332606741
    • Fausto M Mendes, PhD · Sub investigator
    • Marina S Azevedo, PhD · Principal investigator
    • Mariana M Fraga, PhD · Sub investigator
    • Aryane M Menegaz, PhD · Sub investigator
    • Thays V Oliveira, MSc · Sub investigator
08

References and documents

Publications

  • Menegaz AM, Oliveira TTDV, Braga MM, Raggio DP, Cenci MS, Mendes FM, Azevedo MS. Randomized clinical trial to evaluate two methods of caries risk assessment in schoolchildren: the CARDEC-PEL 04 study protocol. BMC Oral Health. 2021 Dec 18;21(1):654. doi: 10.1186/s12903-021-02010-3. PubMed 34922527 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2019 (actual). Primary completion is estimated for Jun 2025, 72 months after the start.

Of 469 non-industry interventional studies with no phase under Dental Caries, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's planned 72 months is above that.

Counting every sponsor, half of 502 studies reached it within 15 months; a quarter within 7 and three quarters within 29.

How these figures are worked out, and which studies are left out of them.

Registered
May 29, 2019
First posted
May 31, 2019
StartActual
Jun 1, 2019
Primary completionEst.
Jun 1, 2025
CompletionEst.
Jun 1, 2028
Last update
Apr 25, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 25, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03969628
Lead sponsor
Federal University of Pelotas
Responsible party
Maximiliano Sergio Cenci (Principal Investigator, Federal University of Pelotas) — Principal investigator
First posted
May 31, 2019
Start date
Jun 1, 2019
Primary completion
Jun 1, 2025 (estimated)
Completion
Jun 1, 2028 (estimated)
Last update
Apr 25, 2023

Study contacts

Marina S Azevedo, PhD
Contact
marinasazevedo@gmail.com
555332602830

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion